30
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
2135679
178559
2

16 magg 2018 anni - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.

Aggiunto al nastro di tempo:

13 nov 2018

Data:

16 magg 2018 anni
Adesso
~ 6 years ago